APO 150 (Nizatidine 150 mg)
Pill imprint APO 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; indigestion; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APO 150 (Nizatidine 150 mg)
- 150 mg
- White & Yellow
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|55045-3748||Dispensing Solutions Inc. (repackager)|
|55887-0153||Diversified Healthcare Services Inc (repackager)|
|23490-6010||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about nizatidine
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...